Sari Elif, Bakar Bulent, Dincel Gungor Cagdas, Budak Yildiran Fatma Azize
Kirikkale University Faculty of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Kirikkale, Turkey.
Kirikkale University Faculty of Medicine, Department of Neurosurgery, Kirikkale, Turkey.
J Plast Reconstr Aesthet Surg. 2017 Apr;70(4):509-517. doi: 10.1016/j.bjps.2017.01.006. Epub 2017 Jan 23.
Dimethyl sulfoxide (DMSO) is an anti-inflammatory, antibacterial, analgesic drug widely used to treat several diseases as reported in the literature. It has a detractive effect on collagen deposition in the abnormal tissue. This study aimed to investigate the possible therapeutic effects of DMSO on hypertrophic scar formation in rabbits. Twenty-four New Zealand male albino rabbits were randomly divided into four groups: control, sham, DMSO, and TRA (triamcinolone acetonide). Except the control group, punch biopsy defects were created on each animal's right ear. Following the hypertrophic scar formation on day 28, intralesional DMSO and triamcinolone acetonide were administered once a week for 4 weeks into these scars of the DMSO and TRA groups, respectively. No therapeutic agent was administered to the control and sham groups. One week after the last injection, ear samples were collected for histopathological, immunohistochemical, and real-time polymerase chain reaction gene expression analyses. Histopathological examination revealed that the epithelium in the DMSO group was thicker than that in the control and TRA groups, but thinner than that in the sham group. Connective tissue thickness and vascularity level of the sham group were higher than those of the control, DMSO, and TRA groups. The collagen type I immunoreactivity level of the sham and TRA groups was higher than those of the control and DMSO groups. The collagen type III immunoreactivity level was higher in the sham group than in all other groups. Collagen type I/type III immunoreactivity ratios were lower in the DMSO group. The alignment of collagen fibers was normal in the DMSO group, but was irregular in the sham and TRA groups. The collagen type I gene expression levels of the DMSO and TRA groups were lower than that of the sham group. Collagen type III and IFN-γ mRNA expression levels were almost similar among the groups. TGF-1β mRNA expression levels were higher in the DMSO and TRA groups than in the control and sham groups. On the basis of the results, it can be concluded that intralesional administration of DMSO decreases hypertrophic scar formation easily and safely.
如文献报道,二甲基亚砜(DMSO)是一种抗炎、抗菌、止痛药物,广泛用于治疗多种疾病。它对异常组织中的胶原蛋白沉积有抑制作用。本研究旨在探讨DMSO对兔增生性瘢痕形成的可能治疗作用。将24只新西兰雄性白化兔随机分为四组:对照组、假手术组、DMSO组和曲安奈德(TRA)组。除对照组外,在每只动物的右耳制造打孔活检缺损。在第28天增生性瘢痕形成后,分别对DMSO组和TRA组的这些瘢痕每周进行一次病灶内注射DMSO和曲安奈德,共4周。对照组和假手术组不给予治疗药物。最后一次注射后1周,收集耳部样本进行组织病理学、免疫组织化学和实时聚合酶链反应基因表达分析。组织病理学检查显示,DMSO组的上皮比对照组和TRA组厚,但比假手术组薄。假手术组的结缔组织厚度和血管化程度高于对照组、DMSO组和TRA组。假手术组和TRA组的Ⅰ型胶原蛋白免疫反应水平高于对照组和DMSO组。假手术组的Ⅲ型胶原蛋白免疫反应水平高于所有其他组。DMSO组的Ⅰ型/Ⅲ型胶原蛋白免疫反应比率较低。DMSO组的胶原纤维排列正常,而假手术组和TRA组不规则。DMSO组和TRA组的Ⅰ型胶原蛋白基因表达水平低于假手术组。各组间Ⅲ型胶原蛋白和IFN-γ mRNA表达水平几乎相似。DMSO组和TRA组的TGF-1β mRNA表达水平高于对照组和假手术组。根据结果可以得出结论,病灶内注射DMSO可轻松、安全地减少增生性瘢痕形成。